Gene silencing

Details for Australian Patent Application No. 2005289769 (hide)

Owner J.R. Simplot Company

Inventors Bougri, Oleg; Yan, Hua; Swords, Kathy M. M.; Rommens, Caius M. T.

Agent Knightsbridge Patent Attorneys

Pub. Number AU-B-2005289769

PCT Pub. Number WO2006/036739

Priority 60/619,959 20.10.04 US; 60/612,638 24.09.04 US; 60/653,609 16.02.05 US; 60/668,071 05.04.05 US

Filing date 23 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 2 December 2010

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/036739 Priority application(s): WO2006/036739

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

17 April 2008 Section 223 Application Allowed

  J.R. Simplot Company The time in which to request examination has been extended to 17 Feb 2008. Address for service in Australia - Knightsbridge Patent Attorneys Level 13 200 Queen Street MELBOURNE VIC 3000

2 December 2010 Application Accepted

  Published as AU-B-2005289769

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289773-Halocombstatins and methods of synthesis thereof

2005289767-Methods for identifying new drug leads and new therapeutic uses for known drugs